|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61P 17/04 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3749353 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19710488.8 |
| Date of filing the European patent application | 2019-02-08 | |
| (97) | Date of publication of the European application | 2020-12-16 |
| (45) | Date of publication and mention of the grant of the patent | 2025-07-30 |
| (46) | Date of publication of the claims translation | 2025-09-25 |
| (86) | Number | PCT/IB2019/051051 |
| Date | 2019-02-08 |
| (87) | Number | WO 2019/155427 |
| Date | 2019-08-15 |
| (30) | Number | Date | Country code |
| 201862628714 P | 2018-02-09 | US |
| (72) |
KERROUCHE, Nabil , FR
HIROKAWA, Keiko , JP
MIHARA, Ryosuke , JP
|
| (73) |
Galderma Holding SA ,
Zählerweg 10, 6300 Zug,
CH
Chugai Seiyaku Kabushiki Kaisha , 5-1, Ukima 5-chome, Kita-ku Tokyo 115-8543, JP |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Nemolizumabas atopinio dermatito, pasireiškiančio vidutinio ar didelio laipsnio ekskoriacija, gydymui |
| NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION |
| Payment date | Validity (years) | Amount | |
| 2026-01-23 | 8 | 185.00 EUR |
| 2027-02-08 |